minoxidil has been researched along with Bone Loss, Osteoclastic in 1 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rutin did not inhibit bone resorption stimulated by hTGF alpha or hTNF." | 1.27 | Use of minoxidil to demonstrate that prostacyclin is not the mediator of bone resorption stimulated by growth factors in mouse calvariae. ( Bosma, TJ; Levine, L; Tashjian, AH, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tashjian, AH | 1 |
| Bosma, TJ | 1 |
| Levine, L | 1 |
1 other study available for minoxidil and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Use of minoxidil to demonstrate that prostacyclin is not the mediator of bone resorption stimulated by growth factors in mouse calvariae.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Animals, Newborn; Bone and Bones; Bone Resorption; Dinoprosto | 1988 |